mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.001 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |